Affiliation:
1. Department of Biological Engineering, Qilu University of Technology, Jinan, Shandong Province 250303, China.
Abstract
Gegensan (GGS) has been reported for the treatment of alcoholic liver disease (ALD), but its therapeutic mechanism is still unclear. This paper aims to determine the therapeutic mechanism and targets of action of GGS on alcoholic liver disease utilizing network pharmacology and bioinformatics. The active ingredients in GGS were screened in the literature and databases, and common targets of ALD were then obtained from public databases to construct the network diagram of traditional Chinese medicine-active ingredient targets. Based on the common targets, Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed to find target enrichment pathways, and the core targets were screened out by combining differential analysis and protein–protein interaction network analysis. Molecular docking was performed to verify the binding effect between the core targets and the corresponding active ingredients. ALD and GGS have 84 common targets, corresponding to 91 active ingredients. After subsequent differential analysis and protein–protein interaction network analysis, 10 core targets were identified. Gene Ontology and KEGG enrichment analyses showed that the main BPs corresponding to the common targets included the response to lipopolysaccharide, inflammatory response, etc. The KEGG pathways involved in the regulation of the common targets included the lipid-atherosclerosis pathway and the alcoholic liver disease pathway, etc. Further molecular docking showed that the core targets CYP1A1, CYP1A2, CXCL8, ADH1C, MMP1, SERPINE1, COL1A1, APOB, MMP1, and their corresponding 4 active ingredients, Naringenin, Kaempferol, Quercetin, and Stigmasterol, have a greater docking potential. The above results suggest that GGS can regulate lipid metabolism and inflammatory response in the ALD process, and alleviate the lipid accumulation and oxidative stress caused by ethanol. This study analyzed the core targets and mechanisms of action of GGS on ALD, which provides certain theoretical support for the further development of GGS in the treatment of ALD, and provides a reference for the subsequent research on the treatment of ALD.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference52 articles.
1. Guidelines for the prevention and treatment of alcoholic liver disease (2018 updated edition).;J Pract Liver Dis,2018
2. Global, regional, and national age-sex specified mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016.;Lancet,2017
3. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METaViR, CLINIVIR, and DOSVIRC groups.;Poynard;Lancet,1997
4. Research progress in epidemiology and pathogenesis of alcoholic liver disease.;Gao;Chin J Gastroenterol Imaging,2016
5. Current status of research on the pathogenesis of alcoholic liver disease.;Wu;J Clin Hepatobiliary Dis,2020